ARCHIVES

Two-Drug Combination Extends Survival Of Mesothelioma

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

In Brief: Shingleton “Unretires” As Director Of Duke Center; O’Brien Interim Head At USC When Hammond Leave

July 24, 1981

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

DCT Advisors Approve Recompetition Of Drug Discovery Groups

June 23, 1995

Court Upholds FDA Position On Definition Of A Drug.

February 23, 2001

Cancer Panel Report Urges Removal Of Barriers To Care.

December 7, 2001